Hereditary hyperferritinemia-cataract syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:163OMIM:600886H26.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare genetic disorder characterized by elevated serum ferritin levels and early-onset bilateral cataracts. It is caused by mutations in the iron-responsive element (IRE) located in the 5' untranslated region of the FTL gene (ferritin light chain gene) on chromosome 19q13. These mutations disrupt the normal regulation of ferritin light chain production, leading to overproduction and accumulation of ferritin in the lens of the eye and elevated ferritin levels in the blood. Importantly, despite the high serum ferritin levels — which can range from 1,000 to over 2,000 µg/L — patients do not have iron overload, and iron studies such as transferrin saturation remain normal. The hallmark clinical features are persistently elevated serum ferritin and bilateral cataracts that typically develop in childhood or early adulthood, though they may be present from birth. The cataracts are caused by crystalline deposits of ferritin light chain (L-ferritin) within the lens and tend to be progressive, often described as having a distinctive 'breadcrumb' or 'sunflower' pattern on slit-lamp examination. Vision impairment varies from mild to significant, depending on the severity and location of the lens opacities. A major clinical concern is that patients are frequently misdiagnosed with hemochromatosis due to the elevated ferritin and may undergo unnecessary phlebotomy or liver biopsy, which can lead to iron deficiency anemia. There is no specific medical treatment to prevent or reverse the cataracts in HHCS. Management is primarily surgical, with cataract extraction performed when visual impairment becomes functionally significant. Cataracts may recur after surgery if lens material remains. Genetic counseling is important for affected families. Awareness of this condition among clinicians is essential to avoid inappropriate treatment for presumed iron overload. The prognosis is generally good, as the condition does not cause organ damage related to iron deposition.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary hyperferritinemia-cataract syndrome.

View clinical trials →

No actively recruiting trials found for Hereditary hyperferritinemia-cataract syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary hyperferritinemia-cataract syndrome community →

No specialists are currently listed for Hereditary hyperferritinemia-cataract syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary hyperferritinemia-cataract syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary hyperferritinemia-cataract syndromeForum →

No community posts yet. Be the first to share your experience with Hereditary hyperferritinemia-cataract syndrome.

Start the conversation →

Latest news about Hereditary hyperferritinemia-cataract syndrome

No recent news articles for Hereditary hyperferritinemia-cataract syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary hyperferritinemia-cataract syndrome

What is Hereditary hyperferritinemia-cataract syndrome?

Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare genetic disorder characterized by elevated serum ferritin levels and early-onset bilateral cataracts. It is caused by mutations in the iron-responsive element (IRE) located in the 5' untranslated region of the FTL gene (ferritin light chain gene) on chromosome 19q13. These mutations disrupt the normal regulation of ferritin light chain production, leading to overproduction and accumulation of ferritin in the lens of the eye and elevated ferritin levels in the blood. Importantly, despite the high serum ferritin levels — which can r

How is Hereditary hyperferritinemia-cataract syndrome inherited?

Hereditary hyperferritinemia-cataract syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.